Hip dysplasia
Follow the links below to find trusted information about hip dysplasia.
Last reviewed: July 2016
Need more information?
These trusted information partners have more on this topic.
Found 37 results
Hip dysplasia | Australian Breastfeeding Association
What is hip dysplasia?
Read more on Australian Breastfeeding Association website
Hip dysplasia in babies
Hip dysplasia is a problem with how a baby’s hip is developing. Find out more about the symptoms, diagnosis and treatment including using a Pavlik harness.
Read more on Pregnancy, Birth & Baby website
Hip dysplasia or DDH: babies & children | Raising Children Network
Developmental dysplasia of the hip affects the hip joint in babies and young children. Health professionals check for DDH at birth and for the first year.
Read more on Raising Children Network website
Parenting and Child Health - Health Topics - Hips - developmental dysplasia of the hip
Developmental Dysplasia of the Hip (DDH) is the name used to describe a range of ways a babys hip might not develop normally. In the past the name Congenital Dislocation of the Hip (CDH) was often used, but not all hip joints that are growing abnormally are dislocated. Dysplasia means growing abnormally.
Read more on Women's and Children's Health Network website
Developmental dysplasia of the hip (DDH) | The Sydney Children's Hospitals Network
Read more on Sydney Children's Hospitals Network website
Women's and Children's Hospital, Adelaide
Perthes disease is the name applied to a condition affecting the upper end, or head, of the thigh bone (femur), where it enters into the formation of the hip joint. In this condition, the growing part of the head of the bone goes through a series of changes, in which it softens, breaks up into fragments, and then gradually re-forms. It is not contagious.
Read more on Women's and Children's Health Network website
Detecting eye problems in babies
A woman complained that her newborn baby had been discharged from hospital without a health examination. A congenital cataract had not been detected, and this led to a delay in diagnosis and treatment of the cataract. As a result, the baby developed a significant visual impairment.
Read more on NSW Health Care Complaints Commission website
Alpha-fetoprotein (AFP) tests in pregnancy - myDr.com.au
An alpha-fetoprotein (AFP) test is a blood test that can show whether your fetus has signs of some birth defects, in particular, spina bifida (a type of neural tube defect).
Read more on myDr website
Cytomegalovirus (CMV) and pregnancy - Factsheets
CMV is a common viral infection, especially among young children. Congenital CMV occurs when the infection is passed across the placenta from a pregnant woman to her developing baby. Some babies with congenital CMV infection show signs of disability at birth, while others are born healthy.
Read more on NSW Health website
Jeans for Genes Day
Jeans for Genes Day is a national day when people wear their jeans to raise much-needed funds for research into birth defects and diseases such as cancer, epilepsy, and a range of genetic disorders.
Read more on Pregnancy, Birth & Baby website
Found 15 results
Screening methods for dislocated or improperly formed hips in newborn infants | Cochrane
The hip joint is a ball and socket joint. Newborns may have hips that are not in their socket (dislocated) or hips that are improperly formed (dysplasia). Risk factors for hip dysplasia include a family history of a similar problem and female infants delivered in the breech position. The hips of most newborns will be examined clinically after birth and during infancy to determine whether they are stable, unstable or dislocated. Screening for hip dysplasia may prevent the need for late treatment, which is associated with long term hip deformity, gait disturbance and arthritis. However, early screening leads to increased treatment. Treatment may be complicated by damage to the hip due to impairment of the blood supply (avascular necrosis).
Read more on Cochrane (Australasian Centre) website
Paediatric, Hip Developmental Dysplasia
This pathway provides guidance on the screening imaging of paediatric patients to exclude developmental dysplasia of the hips.
Read more on Diagnostic Imaging Pathways website
Interventions for the management of submucous cleft palate | Cochrane
Read more on Cochrane (Australasian Centre) website
Late versus early surgical correction for congenital diaphragmatic hernia in newborn infants | Cochrane
Read more on Cochrane (Australasian Centre) website
Prenatal education for congenital toxoplasmosis | Cochrane
Read more on Cochrane (Australasian Centre) website
Folic acid supplements before conception and in early pregnancy (up to 12 weeks) for the prevention of birth defects | Cochrane
Read more on Cochrane (Australasian Centre) website
Folic acid supplements before conception and in early pregnancy (up to 12 weeks) for the prevention of birth defects | Cochrane
Read more on Cochrane (Australasian Centre) website
Prevention of transmission of cytomegalovirus from mother to fetus during pregnancy | Cochrane
There is insufficient evidence from randomised controlled trials to recommend use of any particular intervention to prevent the transmission of cytomegalovirus (CMV) from mother to fetus during pregnancy (congenital CMV infection). CMV is a herpesvirus and is the most common cause of congenital infection in developed countries. Some 40% of women who acquire the infection during pregnancy transmit the virus to their fetus. The fetus can have serious health problems as a result of this infection, including growth restriction and the risk of late miscarriage. While 90% of infants with congenital CMV infection display no manifestations at birth, the remaining 10% do have signs and are at risk of life-long neurological consequences, including cognitive and motor deficits, hearing and visual impairments. Maternal education and behavioural modification are used to limit women acquiring CMV in pregnancy (for example by improved hand hygiene). Drug interventions include antiviral treatment, immunoglobulin therapy (for example CMV hyperimmune globulin) and the possibility of anti-CMV vaccination. There is currently no licensed vaccine against CMV. Antiviral therapy, such as ganciclovir, can be given to the newborn infant to prevent or reduce any consequences of congenital infection. Interventions differ in their efficacy, risks to the baby, possible side effects (such as nephrotoxicity, bone marrow suppression, and emergence of resistant CMV strains) and acceptability of use.
Read more on Cochrane (Australasian Centre) website
Surgery for choanal atresia | Cochrane
Congenital (present from birth) choanal atresia is a rare abnormality characterized by narrowing or blockage of one or both sides of the nasal airway. It has an incidence of between 1 in 5000 and 1 in 8000 births and is two times more common in females. Choanal atresia is treated by surgery, which aims to open the nasal airway sufficiently, avoid harm to any structure in development and result in a low rate of restenosis (renarrowing) after the operation. The procedure should ideally enable the shortest possible surgery and hospitalization time, and minimize morbidity and mortality. Many different techniques and approaches have been described.
Read more on Cochrane (Australasian Centre) website
Plastic and Reconstructive Surgery
Plastic & Reconstructive Surgery
Read more on RACS – Royal Australasian College of Surgeons website
